NTN1 and depressive symptom measurement: Subsequent partial correlation analysis revealed a positive correlation between higher NTN‐1 levels and increased severity of motor symptoms (H‐Y stages and UPDRS scores), depression (HAMD scores), and cognitive function (MMSE and MoCA scores) in PD patients.